Related Experiment Video
Updated: Dec 26, 2025

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease
Published on: April 19, 2021
Modeling Alzheimer's disease in transgenic mice
1Department of Psychiatry, University of South Florida College of Medicine.
Researchers are developing animal models for Alzheimer's disease (AD), a neurodegenerative disorder. Current transgenic models show partial success in replicating AD pathology, with methods and outcomes discussed.
Area of Science:
- Neuroscience
- Genetics
- Pathology
Background:
- Alzheimer's disease (AD) is a prevalent neurodegenerative disorder.
- The exact cause of AD remains unknown.
- Key pathological hallmarks include beta-amyloid plaques and neurofibrillary tangles.
Purpose of the Study:
- To review methods for creating animal models of Alzheimer's disease.
- To discuss the success and limitations of existing transgenic models.
Main Methods:
- Review of various transgenic approaches used in animal modeling.
- Analysis of generated animal models and their characteristics.
Main Results:
- Transgenic animal models for AD have been developed using diverse genetic engineering techniques.
- Current models exhibit partial success in mimicking the complex pathology of Alzheimer's disease.
Conclusions:
- Developing accurate animal models for Alzheimer's disease presents significant challenges.
- Further advancements in transgenic technology are needed to improve model fidelity.
More Related Videos
10:02Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology
Published on: May 28, 2017
08:01Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits
Published on: March 16, 2016